Anemia in Chronic Heart Failure: Unresolved Issues Treatment

Authors

  • Ergasheva Ma’mura Tashtemirovna Assistant of Samarkand State Medical University
  • Khusainova Munira Alisherovna Assistant of Samarkand State Medical University
  • Khaydarov Sanjar Nizamitdinovich Assistant of Samarkand State Medical University
  • Khaydarova Zarrina Erkinovna Assistant of Samarkand State Medical University

Keywords:

heart failure, anemia syndrome, erythropoietin, iron deficiency

Abstract

84 patients with chronic heart failure (CHF) NYHA II-IV FC with anemia were examined. Of these, 54 are men and 30 are women. All patients were diagnosed with anemia at a hemoglobin (Hb) level of less than 120 g/l in men and less than 110 g/l in women. The reason CHF was CHD (postinfarction cardiosclerosis) n=40, or CHD with type 2 diabetes mellitus (DM) n=10, with arterial hypertension (AH) n=14, or CHD +AH+DM n=10. Correction of the anemia syndrome in CHF with the use of MEB, effectively eliminates erythropoietin deficiency, anemia and cytokine aggression in patients with CHF with anemia.

Downloads

Published

2025-03-26

How to Cite

Tashtemirovna , E. M. ., Alisherovna , K. M. ., Nizamitdinovich , K. S. ., & Erkinovna , K. Z. . (2025). Anemia in Chronic Heart Failure: Unresolved Issues Treatment. Miasto Przyszłości, 58, 512–517. Retrieved from https://miastoprzyszlosci.com.pl/index.php/mp/article/view/6242

Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

1 2 > >>